Targeted Therapy for Neuroblastoma: ALK Inhibitors.

Targeted Therapy for Neuroblastoma: ALK Inhibitors.

Item
http://www.wikidata.org/entity/Q38156044
Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.ALK-driven tumors and targeted therapy: focus on crizotinibNeuroblastoma treatment in the post-genomic era.Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo.Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.ARID1B alterations identify aggressive tumors in neuroblastoma.Norcantharidin Inhibits SK-N-SH Neuroblastoma Cell Growth by Induction of Autophagy and Apoptosis.High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma.Targeting ALK in pediatric RMS does not induce antitumor activity in vivo.Embryonale Bauchtumoren im Kindes- und Jugendalter
P2860

Targeted Therapy for Neuroblastoma: ALK Inhibitors.

Item
http://www.wikidata.org/entity/Q38156044
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted Therapy for Neuroblastoma: ALK Inhibitors.
@en
type
label
Targeted Therapy for Neuroblastoma: ALK Inhibitors.
@en
prefLabel
Targeted Therapy for Neuroblastoma: ALK Inhibitors.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Targeted Therapy for Neuroblastoma: ALK Inhibitors
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698